Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer
نویسندگان
چکیده
منابع مشابه
Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
OBJECTIVE The clinical importance of preoperative CYFRA 21-1 measurement in early-stage non-small cell lung cancer (NSCLC) is still unclear. The aim of this study is to clarify the prognostic value of preoperative CYFRA 21-1 levels in clinical stage (c-stage) I NSCLC. METHODS The records of 101 c-stage I NSCLC patients who had undergone complete resection were analyzed to correlate preoperati...
متن کاملPreoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.
PURPOSE This study investigated the preoperative serum levels of CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer. SUBJECTS This study evaluated 341 patients who had undergone a complete resection for stage I NSCLC between 2002 and 2008. RESULTS The patients included 193 males and 148 females. The mean age of the patients was 69.2 years (range: 19...
متن کاملPreoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer.
Cytokeratin 19 is particularly abundant in carcinoma of the lung. The CYFRA 21-1 assay has recently been developed for detection of a cytokeratin 19 fragment in serum. In the current study, the prognostic information provided by the CYFRA 21-1 assay in operable nonsmall cell lung cancer (NSCLC) was analysed. Serum levels of CYFRA 21-1 were measured using an immunoradiometric assay (DiaSorin) in...
متن کاملPreoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
BACKGROUND The aim of this study was to clarify preoperative lung function as a prognostic factor for the long-term survival of, and to discuss the appropriateness of lobectomy for, patients with stage I non-small cell lung carcinoma who have poor preoperative pulmonary function. METHODS The study group consisted of 402 lobectomized patients with stage I non-small cell lung carcinoma treated ...
متن کاملCyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
BACKGROUND Cytokeratins are epithelial markers whose expression is not lost during malignant transformation. Cyfra 21-1 is a cytokeratin-19 fragment that is soluble in serum and may be a useful circulating tumor marker. STUDY OBJECTIVE The aims of this study were (1) to confirm sensitivity and specificity of Cyfra 21-1 in detecting non-small cell lung cancer (NSCLC) and especially the squamou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Cardio-Thoracic Surgery
سال: 2007
ISSN: 1010-7940
DOI: 10.1016/j.ejcts.2007.06.032